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The utility of the dominant-lethal (D-L)
assay as a member of a test battery for the
detection of environmental mutagens is just
beginning to be analyzed. Currently, only a
few laboratories have sufficient experience
with this assay to permit a critical analysis
of its sensitivity and reproducibility. How-
ever, it is already quite evident that a num-
ber of problems plague the usefulness of the
D-L assay; especially those related to ascer-
taining the significance of marginally posi-
tive data and the identification of false or
non-reproducible results.
Test reproducibility is still a matter of
considerable concern to those analyzing D-L
data. Genetic toxicologists are in fair agree-
ment over the necessity of demonstrating a
reproducible test result in the same stage of
spermatogenesis in a dose-related manner.
The important parameters of dead and living
implants per pregnant female should both
reflect the activity of a true mutagen. Pre-
implantation losses have been observed in
the absence of significant increases in deadl
implants/pregnant female. Although such
findings are important in the overall safety
assessment of a given agent, they are not
necessarily indicators of mutagenic activity.
Therefore, such results might better be
analyzed in the context of general reproduc-
tive studies. As additional data become avail-
able on the number of compounds causing
preimplantation losses at specific levels in
*Pfizer Labs, Medical Research Laboratory,
Groton, Connecticut 06340.
D-L tests, the contributory effect of ex-
cessively high dosage regimens can be as-
sessed.
Statistical models, useful in analyzing D-
L data, are now being developed. It is quite
clear that until agreement is reached be-
tween laboratories on the proper model(s)
for use with the D-L assay, conflicting data
will result. The need for a transformation
to reduce the effect of differing variances
which occur in dead and total implants per
pregnant female has been identified and
agreed to by most investigators using the D-
L assay. Currently, there is no overall statis-
tical procedure which has been identified
as most useful in the D-L assay. Until the
power of various statistical procedures for
detecting mutagenic activity have been com-
pared, no single model should be accepted for
general use. However, the comparison of test
data on a weekly or spermatogenic stage
basis with a control regression computed
across the entire eight-week period of sper-
matogenesis appears to satisfy those most
actively investigating the utility of the D-L
assay.
Dose levels of test substances which are
proper for use in mutagenicity studies con-
tinue to be debated. It does appear that many
investigators agree on protocols employing
several levels, the highest of which does not
produce toxic effects. The definition of high-
est dose level used in Segment 2 of the FDA
guidelines for reproductive studies can be
used as a guide.
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ies of animal with large numbers of offspring
and low levels of fetal wastage appears to
be satisfied by several random bred and
hybrid strains of mice available commerci-
ally. However, these strains require constant
monitoring to make sure the infectious dis-
ease burden does not increase to produce an
unacceptable level of fetal wastage. Such
increases reduce the sensitivity of the test
in the detection of weak mutagens.
New test procedures are being examined
for utility in the test battery for mutagene-
sis. The F1 translocation test presented in
the symposium has the apparent advantage
of being more sensitive than the D-L assay
and the benefit of being able to analyze the
genetic constitution of offspring. However,
the duration of the test presents a serious
deterrent to rapid screening of compounds
at a time when such a requirement is most
important. Until more comparative data are
available, the D-L assay will probably have
the greater utility.
The need of a larger information base for
a significant number of chemical classes is
most apparent. A number of collaborative
mutagenicity studies among industrial, gov-
ernment and private laboratories is urgently
needed. Such studies should give baseline
data on important classes of compounds and
prove the utility of the current procedures
in safety evaluation protocols. Standardiza-
tion of procedures is required before the
value of tests such as the D-L can be
broadly assessed. Finally, the results of D-
L testing should be compared to other pro-
cedures such as the cytogenetic and host-
mediated assays to provide the necessary
supportive data for declaring a substance
mutagenic. Factors such as the blood-
testicular barrier could markedly affect test
results and give false impressions of se-
curity. Only after a series of mutagenicity
tests have been performed, which attempt
to measure the kaleideoscopic array of gene-
tic effects produced by chemicals, can the
safety evaluation procedure be considered
complete.
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